Page 11 - ASYMPTOMATIC COVID-19 QUARANTINE DIGITAL SOLUTION: A PROOF-OF-CONCEPT STUDY (NMRR-20-2761-57684)
P. 11

ASYMPTOMATIC COVID-19 QUARANTINE DIGITAL SOLUTION: A PROOF-OF-CONCEPT
                                                                                                              STUDY
                                                                                                               11




                                                                                        2
                                Table 1. COVID-19 diagnosis based on clinical stages


                    Clinical Stage                          Clinical characteristics

                 1  Asymptomatic           •  Only RT-PCR test positive

                                           •  No clinical symptoms
                                           •  No chest imaging findings

                 2  Symptomatic            •  Upper  respiratory  tract  infection  (URTI)  symptoms  (e.g.,
                    without                    pharyngeal congestion, sore throat, cough or fever) for a
                    pneumonia
                                               period less than 7 days

                                           •  No chest imaging findings

                 3  Pneumonia              •  URTI  symptoms  with  others  like  vomiting,  diarrhoea,
                    without hypoxia            abdominal pain, myalgia, loss of smell/ taste

                                           •  Signs  of  increased  work  of  breathing  and  increased

                                               respiratory rate, but no hypoxemia
                                           •  Involvement of lungs as evident by chest imaging

                 4  Pneumonia  with        •  Tachypnoea* with hypoxemia (SpO2<95% on room air)
                    hypoxia                •  CNS  effect:  Lethargy,  decreased  level  of  consciousness,
                    requiring
                    oxygen                     seizure
                    supplementation        •  GI  effects:  Dehydration,  difficulty  feeding,  raised  liver
                    therapy                    enzymes

                                           •  Myocardial effect: Raised Creatinine Kinase, Troponin
                                           •  Involvement of lungs as evident by chest imaging

                 5  Critically ill      Rapid disease progression with:
                                           •  Respiratory failure requiring mechanical ventilation (acute
                                               respiratory distress syndrome (ARDS))

                                           •  Persistent hypoxemia
                                           •  Septic shock
                                           •  Organ failure requiring invasive monitoring and mechanical

                                               ventilation














   TECHNICAL REPORT

   DIGITAL HEALTH RESEARCH AND INNOVATION

   INSTITUTE FOR CLINICAL RESEARCH
   NATIONAL INSTITUTES OF HEALTH
   6   7   8   9   10   11   12   13   14   15   16